HB 2495: Opioid analgesic drugs
Prohibiting pharmacists from substituting opioid analgesic drugs for an opioid analgesic drug incorporating a tamper resistance technology without verifying equivalence or obtaining the written, signed consent of the prescribing physician.
Summary
- Prohibits pharmacists from substituting an opioid analgesic drug for an opioid analgesic drug incorporating tamper resistance properties, unless the drug has substantially similar tamper resistance properties or the prescribing physician provides written consent for the substitution.
From the House Bill Analysis 2012 (HB 2495), written by the Legislature's nonpartisan staff. Read the full report ↗
- IntroducedJan 16, 2012
- Out of committeestopped here
- Passed House
- Passed Senate
- Governor
- Law
- Prime sponsor
- Laurie Jinkins (D-27)
- Introduced
- January 16, 2012 in the House
- Last action
- April 11, 2012
- Companion bill
- SB 6424
- Budget
- Has a fiscal note
AN ACT Relating to prohibiting pharmacists from substituting opioid analgesic drugs for an opioid analgesic drug incorporating a tamper resistance technology without verifying equivalence or obtaining the written, signed consent of the prescribing physician;
Sponsors
Prime sponsor: Laurie Jinkins (D-27)
5 co-sponsors (3 Democrats, 2 Republicans)
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- By resolution, reintroduced and retained in present status.
- By resolution, reintroduced and retained in present status.
- First reading, referred to Health Care & Wellness.
HB 2495 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- HB 2495 (2025–26) Removal of vehicles
- HB 2495 (2023–24) Liquor/clothing and conduct
- HB 2495 (2019–20) Energy recovery facilities
- HB 2495 (2017–18) Academic acceleration prg.
- HB 2495 (2015–16) WSPRS/military service
- HB 2495 (2013–14) Motorcycle helmet standards
- HB 2495 (2009–10) Ballot tabulation
- HB 2495 (2007–08) Municipality parking